Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Brian T. Terrell"'
Publikováno v:
Clinical Medicine Insights: Endocrinology and Diabetes, Vol 2013, Iss 6, Pp 15-24 (2013)
Externí odkaz:
https://doaj.org/article/abfa0cbabdc24030844a6bf2d67b2808
Publikováno v:
Current Diabetes Reviews. 14:509-517
Background Sodium-glucose co-transporter 2 (SGLT2) inhibitors are a new pharmacotherapeutic class for the treatment of Type 2 Diabetes Mellitus (T2DM). Objective To evaluate beneficial effects of the SGLT2 inhibitors on metabolic, cardiovascular, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f9a38d48aa26813fb27e1048378d24f
https://doi.org/10.2174/1573399813666170816142351
https://doi.org/10.2174/1573399813666170816142351
Autor:
Brian T. Terrell, Pamella S. Ochoa
Publikováno v:
MOJ Clinical & Medical Case Reports. 7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a78b56601bf18680e82c66d3355819a
https://doi.org/10.15406/mojcr.2017.07.00217
https://doi.org/10.15406/mojcr.2017.07.00217
Autor:
Celia Lu, Pamella S. Ochoa, Sofia Z. Mnjoyan, Gary W. Binkley, Mary S. Klein, Jose A. Vega, Brian T. Terrell
Publikováno v:
The Annals of pharmacotherapy. 48(11)
Background: Identifying diabetes early in its progression can present opportunities to intervene with education and medical management to prevent diabetes-related complications. Objective: The primary objective was to determine the incidence of diabe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39188828590075c734552e2f230d8123
https://pubmed.ncbi.nlm.nih.gov/25124691
https://pubmed.ncbi.nlm.nih.gov/25124691